Cas:57591-82-9 ethyl 2-imino-3,4-dimethyl-1,3-thiazole-5-carboxylate manufacturer & supplier

We serve Chemical Name:ethyl 2-imino-3,4-dimethyl-1,3-thiazole-5-carboxylate CAS:57591-82-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

ethyl 2-imino-3,4-dimethyl-1,3-thiazole-5-carboxylate

Chemical Name:ethyl 2-imino-3,4-dimethyl-1,3-thiazole-5-carboxylate
CAS.NO:57591-82-9
Synonyms:5-ethoxycarbonyl-3,4-dimethyl-2-imino-4-thiazoline;5-Carbethoxy-3,4-dimethyl-2-imino-4-thiazolin;2-Imino-3,4-dimethyl-2,3-dihydro-thiazole-5-carboxylic acid ethyl ester
Molecular Formula:C8H12N2O2S
Molecular Weight:200.25800
HS Code:2934100090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:268.8ºC at 760mmHg
Density:1.28g/cm3
Index of Refraction:1.583
PSA:83.32000
Exact Mass:200.06200
LogP:1.15090

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 5-ethoxycarbonyl-3,4-dimethyl-2-imino-4-thiazoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Imino-3,4-dimethyl-2,3-dihydro-thiazole-5-carboxylic acid ethyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Carbethoxy-3,4-dimethyl-2-imino-4-thiazolin Use and application,5-Carbethoxy-3,4-dimethyl-2-imino-4-thiazolin technical grade,usp/ep/jp grade.


Related News: The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from pre-clinical studies to low volume commercial manufacture. 3,4-Decadienoic acid, 3-bromo-, ethyl ester manufacturers About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. methyl 3-((1-(1-acetyl-7-chloro-6-methyl-1H-pyrazolo[5,1-c][1,2,4]triazol-3-yl)ethyl)amino)benzoate suppliers After a four-year battle over a cancer drug patent, Novartis has been ordered by a California judge to pay a Daiichi Sankyo subsidiary $177.8 million. Benzene, 2-(diazomethyl)-1,4-dimethoxy- vendor & factory.